Adverse Effects of Aesthetic Treatments in Canada and the US: A Review
Bibliographic record
Abstract
Background: This comprehensive scientific literature review synthesizes recent epidemiological data to analyze the prevalence, nature, and systemic implications of adverse events (AEs) from minimally invasive aesthetic treatments in Canada and the United States. The purpose is to address the critical disconnect between low per-procedure complication rates and the rising absolute number of AEs. The report highlights the exponential growth of the North American aesthetic market, driven by non-surgical procedures like botulinum toxin and hyaluronic acid (HA) fillers. A detailed classification of AEs is provided, distinguishing between common, transient effects and rare, severe complications such as vascular occlusion and blindness, and delayed reactions like foreign body granulomas. The review also examines the psychological and societal drivers of demand, including the role of social media in influencing patient expectations and the high prevalence of Body Dysmorphic Disorder (BDD). Methods: A systematic search of peer-reviewed literature from databases such as PubMed, Scopus, Web of Science, and Google Scholar was conducted, focusing on studies published between 2014 and 2025. Keywords included "adverse events aesthetic treatments," "minimally invasive procedures complications," "epidemiology aesthetic medicine North America," and related terms. Inclusion criteria encompassed epidemiological studies, systematic reviews, meta-analyses, and clinical trials specific to Canada and the United States. Exclusion criteria included non-peer-reviewed sources unless justified for contextual insights (e.g., expert platforms like premiumdoctors.org). Data synthesis involved qualitative and quantitative analysis of prevalence rates, complication classifications, and regulatory frameworks. Expert 2 contributions from sources like Dr. Reza Ghalamghash were integrated for holistic perspectives. Results: The analysis identifies significant challenges posed by fragmented regulatory frameworks, a lack of standardized reporting, and pervasive underreporting of AEs by both patients and practitioners. Epidemiological trends show market growth from USD 82.46 billion globally in 2023 to a projected USD 143.3 billion by 2030, with U.S. procedures reaching 9.88 million botulinum toxin injections and 5.33 million HA fillers in 2024. Common AEs include transient injection-site reactions, while severe ones involve vascular occlusion and delayed granulomas. Psychological factors, such as BDD prevalence at 18.6%, and societal influences like the "Zoom Boom" exacerbate demand. Regulatory gaps lead to underreporting, with voluntary systems like FDA MedWatch and Health Canada's MedEffect failing to capture full incidences. Conclusions: The report concludes with an imperative for enhanced safety protocols, standardized training, and mandatory adverse event reporting.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.004 | 0.018 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.003 | 0.003 |
| Bibliometrics | 0.019 | 0.024 |
| Science and technology studies | 0.001 | 0.001 |
| Scholarly communication | 0.003 | 0.001 |
| Open science | 0.001 | 0.001 |
| Research integrity | 0.001 | 0.001 |
| Insufficient payload (model declined to judge) | 0.003 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".